Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating Activities
Net income	$ 5,331	$ 12,665
Adjustments to reconcile net income to cash used in operating activities:
Depreciation and amortization	34,340	30,949
Other	17,303	4,795
Changes in operating assets and liabilities:
Accounts receivable	(53,268)	57,725
Inventories	38,531	169,083
Commodity derivatives	1,076	(28,498)
Other current and non-current assets	(8,558)	1,923
Payables and other current and non-current liabilities	(384,775)	(488,269)
Net cash used in operating activities	(350,020)	(239,627)
Investing Activities
Purchases of property, plant and equipment and capitalized software	(46,548)	(26,775)
Other	2,717	4,723
Net cash used in investing activities	(43,831)	(22,052)
Financing Activities
Net proceeds (payments) under short-term lines of credit	56,044	(31,913)
Proceeds from issuance of long-term debt	14,700	0
Payments of long-term debt	(8,416)	(6,870)
Distributions to noncontrolling interest owner	0	(44,910)
Dividends paid	(6,693)	(6,516)
Value of shares withheld for taxes	(3,837)	(8,071)
Other	(1,353)	0
Net cash provided by (used in) financing activities	50,445	(98,280)
Effect of exchange rates on cash and cash equivalents	854	7
Decrease in cash and cash equivalents	(342,552)	(359,952)
Cash and cash equivalents at beginning of period	561,771	643,854
Cash and cash equivalents at end of period	$ 219,219	$ 283,902